Incidence of Axillary Adenopathy After COVID-19 Vaccination May Be Lower Than Previously Thought
Prior data suggested the incidence may be as high as 16%.
Prior data suggested the incidence may be as high as 16%.
Order issued as the most populous state in the country struggles to slow infections caused by the highly contagious delta variant.
Mandatory vaccination is especially crucial to protect vulnerable people, including unvaccinated children and those with weakened immune systems.
Considerable variation seen in magnitude of antibody response, from 5 to 7,882 AU/mL, following two doses of mRNA COVID-19 vaccine.
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
37.1 percent of adolescent and young adult cancer survivors report vaccine hesitancy; higher odds of hesitancy for females.
Patients with chronic lymphocytic leukemia had a significantly reduced antibody response rate when compared with healthy individuals.